Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 147

1.

Role of alcohol in the progression of liver disease caused by hepatitis C virus infection.

Ostapowicz G, Watson KJ, Locarnini SA, Desmond PV.

Hepatology. 1998 Jun;27(6):1730-5.

PMID:
9620350
[PubMed - indexed for MEDLINE]
2.

Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study.

Bellentani S, Pozzato G, Saccoccio G, Crovatto M, Crocè LS, Mazzoran L, Masutti F, Cristianini G, Tiribelli C.

Gut. 1999 Jun;44(6):874-80.

PMID:
10323892
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study.

Serfaty L, Chazouillères O, Poujol-Robert A, Morand-Joubert L, Dubois C, Chrétien Y, Poupon RE, Petit JC, Poupon R.

Hepatology. 1997 Sep;26(3):776-9.

PMID:
9303512
[PubMed - indexed for MEDLINE]
4.

Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection.

Westin J, Lagging LM, Spak F, Aires N, Svensson E, Lindh M, Dhillon AP, Norkrans G, Wejstål R.

J Viral Hepat. 2002 May;9(3):235-41.

PMID:
12010513
[PubMed - indexed for MEDLINE]
5.

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.

Poynard T, Bedossa P, Opolon P.

Lancet. 1997 Mar 22;349(9055):825-32.

PMID:
9121257
[PubMed - indexed for MEDLINE]
6.

Severity of liver disease in hepatitis C infection contracted through injecting drug use.

Ostapowicz G, Bell SJ, Desmond PV.

Aust N Z J Med. 1999 Dec;29(6):776-81.

PMID:
10677121
[PubMed - indexed for MEDLINE]
7.

Effect of alcohol consumption on the progression of hepatitis C virus infection and risk of hepatocellular carcinoma in Japanese patients.

Khan KN, Yatsuhashi H.

Alcohol Alcohol. 2000 May-Jun;35(3):286-95.

PMID:
10869250
[PubMed - indexed for MEDLINE]
Free Article
8.

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group.

Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, Vidaud M, Bricaire F, Opolon P, Katlama C, Poynard T.

Hepatology. 1999 Oct;30(4):1054-8.

PMID:
10498659
[PubMed - indexed for MEDLINE]
9.

Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis.

Corrao G, Aricò S.

Hepatology. 1998 Apr;27(4):914-9.

PMID:
9537428
[PubMed - indexed for MEDLINE]
10.

Factors associated with cirrhosis development in chronic hepatitis C patients from an area of low prevalence.

Verbaan H, Widell A, Bondeson L, Andersson K, Eriksson S.

J Viral Hepat. 1998 Jan;5(1):43-51.

PMID:
9493516
[PubMed - indexed for MEDLINE]
11.

HCV genotypes and age distribution in patients of Vienna and surrounding areas.

Haushofer AC, Kopty C, Hauer R, Brunner H, Halbmayer WM.

J Clin Virol. 2001 Jan;20(1-2):41-7.

PMID:
11163582
[PubMed - indexed for MEDLINE]
12.

Correlation between histologic staging, hepatitis C virus genotypes and clinical features in HCV chronic hepatitis: evidence of a new pattern.

Di Tommaso L, Macchia S, Morandi L, Leoncini S, Pession A, Dal Monte PR, Foschini MP.

Int J Surg Pathol. 2003 Jul;11(3):197-204.

PMID:
12894351
[PubMed - indexed for MEDLINE]
13.

Effect of host-related factors on the intensity of liver fibrosis in patients with chronic hepatitis C virus infection.

Costa LB, Ferraz ML, Perez RM, Ferreira AS, Matos CA, Lanzoni VP, Silva AE.

Braz J Infect Dis. 2002 Oct;6(5):219-24.

PMID:
12495603
[PubMed - indexed for MEDLINE]
14.

Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients.

Pol S, Fontaine H, Carnot F, Zylberberg H, Berthelot P, Bréchot C, Nalpas B.

J Hepatol. 1998 Jul;29(1):12-9.

PMID:
9696487
[PubMed - indexed for MEDLINE]
15.

Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study.

Tagger A, Donato F, Ribero ML, Chiesa R, Portera G, Gelatti U, Albertini A, Fasola M, Boffetta P, Nardi G.

Int J Cancer. 1999 May 31;81(5):695-9.

PMID:
10328218
[PubMed - indexed for MEDLINE]
16.

The natural history of childhood-acquired hepatitis C infection in patients with inherited bleeding disorders.

Posthouwer D, Fischer K, van Erpecum KJ, Mauser-Bunschoten EP.

Transfusion. 2006 Aug;46(8):1360-6.

PMID:
16934072
[PubMed - indexed for MEDLINE]
17.

The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.

Di Martino V, Rufat P, Boyer N, Renard P, Degos F, Martinot-Peignoux M, Matheron S, Le Moing V, Vachon F, Degott C, Valla D, Marcellin P.

Hepatology. 2001 Dec;34(6):1193-9.

PMID:
11732009
[PubMed - indexed for MEDLINE]
18.

Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients.

Cholet F, Nousbaum JB, Richecoeur M, Oger E, Cauvin JM, Lagarde N, Robaszkiewicz M, Gouérou H.

Gastroenterol Clin Biol. 2004 Mar;28(3):272-8.

PMID:
15094677
[PubMed - indexed for MEDLINE]
Free Article
19.

Intrahepatic hepatitis C virus replication is increased in patients with regular alcohol consumption.

Romero-Gómez M, Grande L, Nogales MC, Fernández M, Chavez M, Castro M.

Dig Liver Dis. 2001 Nov;33(8):698-702.

PMID:
11785717
[PubMed - indexed for MEDLINE]
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk